Skip to main content
Premium Trial:

Request an Annual Quote

Kinneret Savitsky, Dorit Bitter, Michal Preminger, Aram Adourian, Ken Olisa, Russell Singleton


Kinneret Savitsky, VP of biology R&D; Dorit Bitter, VP of computational life sciences R&D; and Michal Preminger, VP of protein therapeutics, will be leaving Compugen, the company said last week. “The three are independent incidences and have nothing to do with one another,” said a Compugen spokeswoman.

Aram Adourian has been named VP of computational sciences at Beyond Genomics. He joins the firm from the Whitehead Institute for Biomedical Research at MIT, where he was a founding member of the BioMEMS applied sciences laboratory and served as project manager for bioinformatics.

BioWisdom has appointed Ken Olisa as a non-executive director of the company. Olisa is chairman and CEO of Interregnum, a technology merchant bank that he founded in 1992.

Russell Singleton has joined Perlegen Sciences as VP of engineering and informatics. Singleton led the instrumentation and software development programs at Molecular Dynamics. More recently, as president of his own firm, he led the development of business and marketing strategies for biotechnology firms and semiconductor capital equipment companies.

Filed under

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.